#BEGIN_DRUGCARD DB04023

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C16H23N5O17P2

# Chemical_IUPAC_Name:
(2R,3R,4R,5S,6R)-6-({[({[(2S,3R,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester

# HET_ID:
GDX

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C16H23N5O17P2/c17-16-19-11-4(12(27)20-16)18-2-21(11)13-8(25)5(22)3(35-13)1-34-39(30,31)38-40(32,33)37-15-9(26)6(23)7(24)10(36-15)14(28)29/h2-3,5-10,13,15,22-26H,1H2,(H,28,29)(H,30,31)(H,32,33)(H3,17,19,20,27)/t3-,5-,6+,7+,8+,9-,10+,13+,15+/m0/s1

# InChI_Key:
InChIKey=DNBSDUDYNPJVCN-KXHDAMSKSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4023

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
619.3246

# Molecular_Weight_Mono:
619.056417359

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1MV8

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.6

# Predicted_LogS:
-1.9

# Predicted_Water_Solubility:
7.60e+00 g/l

# Primary_Accession_No:
DB04023

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936863

# PubChem_Substance_ID:
46508808

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01577

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC2=C(N=CN2[C@@H]2O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)O[C@H]3O[C@H]([C@H](O)[C@@H](O)[C@@H]3O)C(O)=O)[C@H](O)[C@H]2O)C(=O)N1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:52 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Y00337

# Drug_Target_1_GenBank_ID_Protein:
45268

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
algD

# Drug_Target_1_Gene_Sequence:
>1311 bp
ATGCGAATCAGCATCTTTGGTTTGGGCTATGTCGGTGCAGTATGTGCTGGCTGCCTGTCG
GCACGCGGTCATGAAGTCATTGGTGTGGATGTCTCCAGCACCAAGATCGACCTGATCAAC
CAGGGCAAGTCGCCCATCGTCGAACCGGGCCTGGAAGCGTTGTTGCAGCAAGGCCGGCAG
ACCGGACGGCTGTCGGGCACCACCGACTTCAAGAAGGCTGTGCTGGACTCCGACGTATCG
TTCATCTGCGTCGGCACGCCGAGCAAGAAGAACGGCGACCTGGACCTGGGCTACATCGAG
ACCGTCTGCCGCGAGATCGGCTTCGCCATCCGCGAGAAGTCCGAACGCCACACCGTGGTG
GTGCGCAGCACCGTACTGCCGGGCACCGTCAACAACGTGGTGATCCCGCTGATCGAGGAC
TGCTCGGGCAAGAAGGCCGGGGTCGACTTCGGCGTCGGCACCAACCCCGAATTCCTCCGC
GAGAGCACCGCGATCAAGGACTACGACTTCCCGCCGATGACCGTGATCGGCGAACTGGAC
AAGCAGACCGGCGACCTTCTCGAGGAAATCTACCGCGAGCTGGACGCGCCGATCATCCGC
AAGACCGTCGAGGTCGCCGAGATGATCAAGTACACCTGCAACGTCTGGCACGCCGCCAAG
GTCACCTTCGCCAACGAGATCGGCAACATCGCCAAGGCGGTCGGCGTCGACGGCCGCGAG
GTGATGGACGTGATCTGCCAGGACCACAAGCTCAACCTGTCGCGCTACTACATGCGTCCC
GGCTTCGCCTTCGGCGGCTCCTGCCTGCCCAAGGATGTACGCGCCCTCACCTATCGCGCC
AGCCAGCTGGACGTCGAGCACCCGATGCTCGGTTCGTTGATGCGCAGCAACTCCAACCAG
GTGCAGAAGGCCTTCGATCTCATCACCAGCCACGACACCCGCAAGGTCGGCCTGCTCGGC
CTGTCGTTCAAGGCCGGCACCGACGATTTGCGCGAAAGCCCGCTGGTGGAGCTGGCCGAG
ATGCTCATCGGCAAGGGCTACGAGTTCCGCATCTTCGACCGCAACGTCGAATACGCGCGT
GTCCACGGGGCCAACAAGGAATACATCGAGTCGAAGATCCCGCACGTCTCCTCGCTGCTG
GTCTCCGACCTCGACGAAGTGGTGGCGAGTTCCGATGTGCTGGTGCTGGGCAATGGCGAC
GAGCTGTTCGTCGACCTGGTGAACAAGACCCCGAGCGGCAAGAAGCTGGTCGACCTGGTG
GGCTTCATGCCGCACACCACCACTGCCCAGGCCGAGGGCATCTGCTGGTAG

# Drug_Target_1_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_1_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
12135385	Naught LE, Gilbert S, Imhoff R, Snook C, Beamer L, Tipton P: Allosterism and cooperativity in Pseudomonas aeruginosa GDP-mannose dehydrogenase. Biochemistry. 2002 Jul 30;41(30):9637-45.
12705829	Snook CF, Tipton PA, Beamer LJ: Crystal structure of GDP-mannose dehydrogenase: a key enzyme of alginate biosynthesis in P. aeruginosa. Biochemistry. 2003 Apr 29;42(16):4658-68.
1370473	Roychoudhury S, Chakrabarty K, Ho YK, Chakrabarty AM: Characterization of guanosine diphospho-D-mannose dehydrogenase from Pseudomonas aeruginosa. Structural analysis by limited proteolysis. J Biol Chem. 1992 Jan 15;267(2):990-6.
2470755	Roychoudhury S, May TB, Gill JF, Singh SK, Feingold DS, Chakrabarty AM: Purification and characterization of guanosine diphospho-D-mannose dehydrogenase. A key enzyme in the biosynthesis of alginate by Pseudomonas aeruginosa. J Biol Chem. 1989 Jun 5;264(16):9380-5.
3108855	Deretic V, Gill JF, Chakrabarty AM: Pseudomonas aeruginosa infection in cystic fibrosis: nucleotide sequence and transcriptional regulation of the algD gene. Nucleic Acids Res. 1987 Jun 11;15(11):4567-81.
8294014	Maharaj R, May TB, Wang SK, Chakrabarty AM: Sequence of the alg8 and alg44 genes involved in the synthesis of alginate by Pseudomonas aeruginosa. Gene. 1993 Dec 22;136(1-2):267-9.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3367

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
47600

# Drug_Target_1_Name:
GDP-mannose 6-dehydrogenase

# Drug_Target_1_Number_of_Residues:
436

# Drug_Target_1_PDB_ID:
1MV8

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00984	UDPG_MGDP_dh
PF03720	UDPG_MGDP_dh_C
PF03721	UDPG_MGDP_dh_N

# Drug_Target_1_Protein_Sequence:
>GDP-mannose 6-dehydrogenase
MRISIFGLGYVGAVCAGCLSARGHEVIGVDVSSTKIDLINQGKSPIVEPGLEALLQQGRQ
TGRLSGTTDFKKAVLDSDVSFICVGTPSKKNGDLDLGYIETVCREIGFAIREKSERHTVV
VRSTVLPGTVNNVVIPLIEDCSGKKAGVDFGVGTNPEFLRESTAIKDYDFPPMTVIGELD
KQTGDLLEEIYRELDAPIIRKTVEVAEMIKYTCNVWHAAKVTFANEIGNIAKAVGVDGRE
VMDVICQDHKLNLSRYYMRPGFAFGGSCLPKDVRALTYRASQLDVEHPMLGSLMRSNSNQ
VQKAFDLITSHDTRKVGLLGLSFKAGTDDLRESPLVELAEMLIGKGYELRIFDRNVEYAR
VHGANKEYIESKIPHVSSLLVSDLDEVVASSDVLVLGNGDELFVDLVNKTPSGKKLVDLV
GFMPHTTTAQAEGICW

# Drug_Target_1_Reaction:
GDP-D-mannose + 2 NAD+ + H2O = GDP-D-mannuronate + 2 NADH + 2 H+

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the oxidation of guanosine diphospho-D-mannose (GDP-D-mannose) to GDP-D-mannuronic acid, a precursor for alginate polymerization. The alginate layer causes a mucoid phenotype and provides a protective barrier against host immune defenses and antibiotics

# Drug_Target_1_SwissProt_ID:
P11759

# Drug_Target_1_SwissProt_Name:
ALGD_PSEAE

# Drug_Target_1_Synonyms:
EC 1.1.1.132
GMD

# Drug_Target_1_Theoretical_pI:
5.35

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04023
